Inventor · disambiguated record
Kazuaki Takami
Also filed as: TAKAMI KAZUAKI
19 granted patents·6 pending applications·41 citations·filing 2009–2024
92Inventor score
Top patents by PatentIndex Score
25 records- 0191US11236099B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 1, 2022·4 cites·22 claims
- 0291US10214498B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Feb 26, 2019·4 cites·12 claims
- 0389US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 0489US10544111B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 28, 2020·3 cites·41 claims
- 0588US9890145B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 13, 2018·8 cites·10 claims
- 0685US11560372B2Heterocyclic compounds useful as modulators of acetylcholine receptorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 24, 2023·2 cites·4 claims
- 0785US11186565B2Aromatic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 30, 2021·3 cites·10 claims
- 0884US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 0983US10975043B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Apr 13, 2021·1 cites·2 claims
- 1081US9321757B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Granted Apr 26, 2016·5 cites·13 claims
- 1178US11407748B2Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor functionTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 9, 2022·1 cites·12 claims
- 1275US9975903B2Condensed heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 22, 2018·2 cites·11 claims
- 1373US12024505B2Heterocyclic compounds useful as modulators of acetylcholine receptorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jul 2, 2024·0 cites·12 claims
- 1470US2021340114A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1566US12378256B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 1665US8937055B2Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating actionUJIKAWA OSAMU·Filed 2011·Granted Jan 20, 2015·2 cites·11 claims
- 1763US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1862US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1961US11970483B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 30, 2024·0 cites·16 claims
- 2060US12162864B2Condensed-cyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
- 2150US2023348435A11-((1h-pyrazol-4-yl)methyl)-3-(phenyl)-1,3-dihydro-2h-imidazol-2-one derivatives and related compounds as gpr139 antagonists for the treatment of e.g. depressionTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2250US2011015225A1Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 2349US2022289679A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 2442US11459325B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 4, 2022·0 cites·10 claims
- 2537US9944596B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Apr 17, 2018·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Kazuaki Takami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →